₹ 838.00
-10.70 (-1.26%)
E
Expleo Solutions
₹ 838.00
Expleo Solutions Share Price Today
Expleo Solutions (EXPLEOSOL) share price is trading at ₹838.00 on the NSE as of November 9, 2026 at 03:29 PM, down by 1.26% from its previous close of ₹848.70. In todays trading session EXPLEOSOL reached a high of 855.25 and low of 826.90. The average traded price for today is 834.52. The 50 DMA stands at 860.08 and 200 DMA is at 833.71. Looking at intraday trend, the stock is in Downtrend.
Stock Overview
- Symbol : EXPLEOSOL
- Open : ₹855.25
- Previous Close : ₹848.70
- Day's Range : ₹826.90 – ₹855.25
- 52-Week Range : ₹640.00 – ₹1,175.10
- Upcoming Event : Q2 FY 26-27 Results (14th Nov 2026, Saturday)
Get 20+ Chart Types, 180+ Indicators, 80+ Drawing Tools & Create Custom Indicators for FREE.
EXPLEOSOL Stock Performance
Markets Today
High
855.25
Low
826.90
Open at
855.25
Prev Close
848.70
Volumes
6,206
Avg Price
834.52
Lower Circuit
670.40
Upper Circuit
1,005.60
Last Traded Details
Quantity
13
Time
15:29:56
Price Movement
Historical Performance
3 M High
945.90
3 M Low
790.35
1 Yr High
1,175.10
1 Yr Low
640.00
3 Yr High
1,567.45
3 Yr Low
640.00
5 Yr High
1,874.00
5 Yr Low
640.00
1-Year Performance
EXPLEOSOL Pros and Cons
BFSI revenue share grows from 80.8% to 82.0% from Q1 FY26 to Q1 FY27 — core business dominance strengthens
Enterprise clients (>$1Mn revenue) increase from 28 to 33 from Q1 FY26 to Q1 FY27 — successful large-account expansion
Europe revenue share rises from 51.6% to 57.2% from Q1 FY26 to Q1 FY27 — steady regional market penetration
Net cash position climbs from ₹2,382 Cr to ₹3,528 Cr from Q1 FY26 to Q1 FY27 — strong financial flexibility maintained
Top 10 client contribution falls from 54% to 51% from Q1 FY26 to Q1 FY27 — revenue concentration risk reduces
Auto revenue share declines from 10.7% to 8.0% from Q1 FY26 to Q1 FY27 — sustained portfolio shift away from the segment
Adjusted EBITDA margin contracts from 16.6% to 14.5% from Q3 FY26 to Q1 FY27 — pricing and cost pressures mount
Debtors days rebound from 85 days to 108 days from Q3 FY26 to Q1 FY27 — slower cash collection cycles emerge
Finance cost surges from ₹4.2 Cr to ₹11.6 Cr from Q3 FY26 to Q1 FY27 — heavier debt servicing burden takes hold
PAT margin drops from 16.5% to 11.8% from Q4 FY26 to Q1 FY27 — near-term earnings compression continues
EXPLEOSOL Analyst Rating
Buy
Analysts have suggested that investors can
Buy this Stock
- By Refinitiv from 1 analysts
Buy
100%
Hold
0%
Sell
0%
Get forecast for Price, ROA & ROE based on analyst ratings.
EXPLEOSOL Share Price History
EXPLEOSOL Fundamentals
Company Valuation
Market Cap (₹ Cr.)
1,301
PE Ratio
9.60
PB Ratio
1.70
Dividend Yield
12.96%
ROE
15.97%
ROCE
20.58%
Book Value (₹)
500.21
Face Value (₹)
10.00
Analyse EXPLEOSOL with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|
| Promoters | 71.05% | 71.05% | 71.05% | 71.05% | 71.05% |
| Domestic Institutional Investors (DII) | 0.84% | 0.07% | 0.01% | 0.12% | 0.39% |
| Foreign Institutional Investors (FII) | 0.13% | 0.32% | 0.42% | 0.13% | 0.16% |
| Public Investors | 22.60% | 23.07% | 22.94% | 23.57% | 23.46% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
Expleo Solutions Return Calculator
Note: Past profits do not guarantee future returns.
EXPLEOSOL Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
EXPLEOSOL Technicals
Moving Averages
Technical Indicators
Summary of Technical Indicators for EXPLEOSOL
Margin on EXPLEOSOL
*Calculated on NSE. Applicable on all exchanges. Margins are subject to change from time to time or may be withdrawn under volatile market conditions. Intraday Orders are square-off automatically at 03:19 pm on NSE / BSE or on hitting 80% of margin utilisation (whichever earlier).
EXPLEOSOL Financials Summary
In Crores
EXPLEOSOL Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Corporate Actions
The above dates are ex-dates.
Check EXPLEOSOL latest Company Filings, Investor Presentation & Conference Call details.
EXPLEOSOL Revenue Growth
All values are in Crores
Revenue
Profit
Loss
EXPLEOSOL Similar Stocks
FAQs on EXPLEOSOL
What is the share price of Expleo Solutions?
What is the 52W high and 52W low of Expleo Solutions?
What is the return on Expleo Solutions share?
- Past 1 year: -14.51%
- Past 3 years: -36.93%
- Past 5 years: -25.70%
What is the PE and PB Ratio of Expleo Solutions?
What is the EPS of Expleo Solutions?
What is the shareholding pattern of Expleo Solutions?
- DIIs - 0.39%
- FII - 0.16%
- Promoters - 71.05%
- Public Investors 23.46%
- Goverenment - 0.00%
How to buy Expleo Solutions shares online?
How to buy Expleo Solutions shares on Dhan?
- Download the Dhan App to Open a Demat Account
- Navigate to the “Money Tab”
- Add money to your account
- Search for Expleo Solutions share
- Tap on “Buy”
